Periportal fibrosis in Schistosoma mansoni Mono and Malaria- Schistosoma Co-infected Individuals in Finchaa Sugar Estate, Western Ethiopia

Authors

  • Mebrate Dufera Wallaga University
  • Nega Berhe Addis Ababa University
  • Beyene Petros Addis Ababa University
  • Berhanu Erko Addis Ababa University

DOI:

https://doi.org/10.20372/mhsr.v1i1.7

Keywords:

Co-infections, Co-morbidity, Periportal fibrosis, Plasmodium falciparum, Plasmodium vivax, Finchaa Sugar Estate

Abstract

In Ethiopia where malaria parasite and Schistosoma mansoni infections are co-endemic, the general population is quite vulnerable both to malaria and Schistosoma mansoni infections singly or concomitantly. However, data on PPF due to single and co-infections are lacking. The aim of this study was to assess the status of PPF in S. mansoni mono infected and malaria-S. mansoni co-infected individuals. A community based cross sectional study was conducted in Finchaa Sugar Estate, western Ethiopia. Schistosomal periportal and portal liver fibrosis were determined by ultrsonography. SPSS statistical software version 20 was used and P-value <0.05 was reported as statistically significant. The findings of this study showed that P. falciparum and S. mansoni co-infection reciprocally increase the degree of PPF. The study has provided an additional sonographic data on the reciprocal effects of P. falciparum and S. mansoni co-infection, and could serve as a guide in designing, developing and implementing intervention strategies to mitigate co-morbidity due to co-infection among the high risk groups in Ethiopia and other endemic areas of the world.

Downloads

Download data is not yet available.

Author Biographies

Mebrate Dufera, Wallaga University

Department of Biology, Wallaga University, Post Box No: 395, Nekemte, Ethiopia

Nega Berhe, Addis Ababa University

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Post Box No: 1176, Addis Ababa, Ethiopia,

Centre for Imported and Tropical Diseases, Oslo University Hospital-Ulleval, Kirkeveien, Oslo, Norway

Beyene Petros, Addis Ababa University

Department of Microbial, Cellular and Molecular Biology, Addis Ababa University, Post Bo No: 1176,
Addis Ababa, Ethiopia

Berhanu Erko, Addis Ababa University

Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Post Box No: 1176, Addis Ababa, Ethiopia

References

Abebe, N., Erko, B., Medhin, G. and Berhe, N. (2014). Clinico-epidemiological study of Schistosoma mansoni in Waja-Timuga, District of Alamata, northern Ethiopia. Parasites and Vectors 7: 158.

Aemero, M., Boissier, J., Climent, D., Moné, H., Mouahid, G., Berhe, N. and Erko, B. (2015). Genetic diversity, multiplicity of infection and population structure of

Schistosoma mansoni isolates from human hosts in Ethiopia. BioMed Central Genetics 16: 1-12.

Baptista, A., Bianchi, L., DeGroote, J., Desmet, V.J., Ishak, K.G., Korb, G., MacSween, R.N.M., Popper, H., Poulsen, H., Scheuer, P.J., Schmid, M. and Thaler, H. (1988). The diagnostic significance of periportal hepatic necrosis and inflammation. Histopathology 12(6): 569-579.

Barsoum, R.S., Esmat, G. and El-Baz, T. (2013). Human Schistosomiasis: Clinical Perspective: Review. Journal of Advanced Research 4: 433-444.

Berhe, N., Myrvang, B. and Gundersen, S. G. (2007). Intensity of Schistosoma Mansoni, Hepatitis B, age, and sex predict levels of hepatic periportal thickening/fibrosis (PPT/F): A large-scale community- based study in Ethiopia. American Journal of Tropical Medicine and Hygiene 77(6): 1079-1086.

Bodh, V. and Chawla, Y.K. (2014). Non cirrhotic intra hepatic portal hypertension. Clinical Liver Disease 3: 129- 132.

Booth, M., Mwatha, J. K., Joseph, S., Jones, F. M., Kadzo, H., Ireri, E., Kazibwe, F., Kemijumbi, J., Kariuki, C., Kimani, G., Ouma, J.H., Kabatereine, N.B., Vennervald,

B.J. and Dunne, D.W. (2004a). Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. Journal of Immunology 172(2): 295-303.

Booth, M., Vennervald, B.J., Kenty, L., Butterworth, A.E., Kariuki, H.C., Kadzo, H., Ireri, E., Amaganga, C., Gachuhi, K., Mwatha, J.K., Otedo, A., Ouma, J. and Dunne, D. W. (2004b). Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children. BioMed Central Infectious Diseases. 4: 13.

Booth, M., Vennervald, B.J., Butterworth, A.E., Kariuki, H.C., Amaganga, C., Kimani, G., Mwatha, J.K., Otedo, A., Ouma, J.H. and Dunne, D.W. (2004c). Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children. BioMed Central Medicine 2: 36.

Cheever, A.W. and Andrade, Z. (1967). Pathological lesions associated with Schistosoma mansoni infection in man. Transactions Royal Society Tropical Medicine and Hygine.61:626–639.

Faye, B., Ndiaye, J.L., Tine, R.C., Lo, A.C. and Gaye, O. (2008). Interaction between malaria and intestinal helminthiasis in Senegal: influence of the carriage of intestinal parasites on the intensity of the malaria infection. Bulletin De La Societe De Pathologie Exotique 101: 391–394.

FMoH (2004). Malaria diagnosis and treatment guidelines for health workers in Ethiopia. 2nd ed. Federal Democratic Republic of Ethiopia Ministry of Health. Addis Ababa. 58 pp.

Franke, D., Kaiser, C., Elsheikh, M., Abdalla, S., Schafer, P. and Ehrich, J.H.H.(1991). Ultrasonographic investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. American Journal of Tropical. Medicine and Hygiene.44: 444-451.

Henri, S., Chevillard, C., Mergani, A., Paris, P., Gaudart, J., Camilla, C., Dessein, H., Montero, F., Elwali, N.M.A., Saeed, O.K., Magzoub, M. and Dessein, A.J. (2002). Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is

associated with protection against fibrosis and TNF-alpha with aggravation of disease. Journal of Immunology 169: 929–936.

Homeida, M.A., Ahmed, S., Dafalla, A., Suliman, S., Eltom, I., Nash, T. and Bennett, J.L. (1988). Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. American Journal of Tropical Medicine and Hygiene .39: 196–201.

Mazigo, H.D., Waihenya, R., Lwambo, N.J.S., Mnyone, L.L., Mahande, A.M. and Seni, J., Zinga, M., Kapesa, A., Kweka, E.J., Mshana, S.E., Heukelbach, J. and Mkoji, G.M.(2010). Co-infections with Plasmodium falciparum, Schistosoma mansoni and intestinal helminths among schoolchildren in endemic areas of northwestern Tanzania. Parasites & Vectors. 3:1-7.

Mohamed-Ali, Q., Elwali, N.E., Abdelhameed, A.A., Mergani, A., Rahoud, S., Elagib, S.K.E., Saeed, O.K., Abel,L., Magzoub, M.M.A. and Dessein, A.J.(1999). Susceptibility to periportal (Symmers) fibrosis in human Schistosoma mansoni infections: evidence that intensity and duration of infection, gender, and inherited factors are critical in disease progression. Journal of Infectious Diseases. 180: 1298-1306.

Ribeiro de Jesus, A.R., Magalha˜es, A., Miranda, DG., Miranda, R.G., Arau´jo, M.I., de Jesus, A.A., Silva, A., Santana, L.B., Pearce, E. and Carvalho, E.M. (2004). Association of Type 2 Cytokines with Hepatic Fibrosis in Human Schistosoma mansoni Infection. Infection and Immunity 72(6): 3391-3397.

Richter, J., Hatz, C., Campagne, G., Bergquist, N.R. and Jenkins, J.M. (2000). Ultrasound in schistosomiasis. A practical guide to the standardized use of Ultrasonography for the assessment of schistosomiasis related morbidity. World Health Organization, Geneva.

Sokhna, C., Le Hesran, J.Y., Mbaye, P.A., Akiana, J., Camara, P., Diop, M., Abdoulaye, L.y. and Druilhe, P. (2004). Increase of malaria attacks among children presenting concomitant infection by Schistosoma mansoni in Senegal. Malaria Journal 12:43.

van der Werf, M., de Vlas S., Brooker, S., Looman, C., Nagelkerke, N., Habbema, J.D.F and Engels,D.(2003). Quantification of clinical morbidity associated with Schistosome infection in Sub-Saharan Africa. Acta Tropica 86 (2): 125-139.

Whittle, H., Gelfand, M., Sampson, E., Purvis, A. and Weber,

M. (1969). Enlarged livers and spleens in an area endemic for malaria and schistosomiasis. Transactions Royal Society Tropical Medicine and Hygine 63: 353-361.

Wilson, S., Jones, F.M., Mwatha, J.K., Kimani, G., Booth, M., Kariuki, H.C., B.J. Vennervald, B.J., Ouma, J.H., MuchirI,

E. and Dunne. D.W. (2009). Hepatosplenomegaly associated with chronic malaria exposure: evidence for a proinflammatory mechanism exacerbated by schistosomiasis. Parasite Immunology 31(2): 64-71.

Downloads

Published

2023-04-29

How to Cite

Dufera, M., Berhe, N., Petros, B., & Erko, B. (2023). Periportal fibrosis in Schistosoma mansoni Mono and Malaria- Schistosoma Co-infected Individuals in Finchaa Sugar Estate, Western Ethiopia. Medical and Health Sciences Research Journal, 1(1), 01–06. https://doi.org/10.20372/mhsr.v1i1.7

Issue

Section

Articles

Categories

Plaudit